Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advi... ( Leader in single molecule detection t...)

Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board

Date:11/11/2008

Leader in single molecule detection to expand prominent Scientific Advisory

Board

CAMBRIDGE, Mass., Nov. 11 /PRNewswire/ -- Quanterix Corporation, the leader in single molecule detection, announced today that Robert Corn, Ph.D. has joined its Scientific Advisory Board (SAB). Dr. Corn is a Professor in the Departments of Chemistry and Biomedical Engineering at the University of California, Irvine. Dr. Corn's primary research areas include the development of new methods for detecting binding of biomolecules to surfaces and chemical modification strategies to control specific and non-specific adsorption of biopolymers to a variety of surfaces.

Dr. David Walt, Scientific Founder of Quanterix and Chair of the SAB, stated, "Dr. Corn is a leader in the field of surface chemistry; his research interests and experience are directly applicable to our Single Molecule Array (SiMoA(TM)) technology. We are eager to draw upon his extensive knowledge and insight as we develop assays and instrumentation that enable unparalleled increases in analytical sensitivity for the detection of proteins implicated in a variety of diseases."

Dr. Corn added, "The novel technology platform being developed by Quanterix will provide medical researchers with a unique tool that allows low abundance biomarkers to be detected in complex biological samples. I am excited to join such a world class Advisory Board and look forward to working with the other members to further advance this promising technology."

Dr. Corn joins SAB members David Walt, Ph.D., Robinson Professor of Chemistry and Howard Hughes Medical Institute Professor, Tufts University (Chairman of the SAB), Larry J. Kricka, D. Phil., Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and Director of the General Chemistry Laboratory at the Hospital of the University of Pennsylvania, J. Michael Ramsey, Ph.D., Minnie N. Goldby Distinguished Profess
'/>"/>

0

GOOD

Page: 1 2
Related biology technology :

1. Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine
2. Medical Simulation Corporation Announces Partnership With University of South Florida
3. Environmental Power Corporation and Organix, Inc. Establish Alliance to Produce High Value Soil Amendment Products
4. Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division
5. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
6. Health Robotics Announces Contract for its CytoCare(TM) and IV Station(TM) Robots With Arabian Health Care Supply Corporation
7. DURECT Corporation Announces Third Quarter 2008 Financial Results
8. Verenium Corporation to Announce Third Quarter 2008 Financial Results
9. Environmental Tectonics Corporations Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety
10. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
11. STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results

Post Your Comments:

Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advi...( Leader in single molecule detection t...)